1.
Omar RMK, Najar AM, Bobtaina E, Elsheikh AF. Pryazolylpyridine and Triazolylpyridine derivative of hydroxychloroquine as Potential Therapeutic against COVID-19: Theoretical Evaluation. J. Drug Delivery Ther. 2020;10(4-s):181-186. doi:10.22270/jddt.v10i4-s.4298